GSK Reports Higher Third-Quarter Sales, Boosted by Specialty Medicines
GSK said third-quarter turnover was 8.89 billion pounds ($11.83 billion), with growth boosted by its specialty medicines segment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.